Work

WS12-4 Long-term safety and efficacy of lumacaftor/ivacaftor therapy in patients aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation (F/F)

Year: 2019

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(19)30189-4

Authors: M. Chilvers, J.C. Davies, F. Ratjen, C. Milla, C.A. Owen, S. Tian, Z. Han, L.T. Wang

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2947527255

FWCI: 0.165

Cites:

Cited by: 2

Related to: 10